| Harris Galkin, MD | |
|
450 Veterans Memorial Pkwy, East Providence, RI 02914-5300 | |
| (401) 434-7853 | |
| Not Available |
| Full Name | Harris Galkin |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 450 Veterans Memorial Pkwy, East Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770500084 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD5884 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Harris Galkin, MD 450 Veterans Memorial Pkwy, East Providence, RI 02914-5300 Ph: (401) 434-7853 | Harris Galkin, MD 450 Veterans Memorial Pkwy, East Providence, RI 02914-5300 Ph: (401) 434-7853 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced a positive outcome from a pivotal Phase II clinical trial conducted by Roche and Genentech, Curis' collaborator and a wholly owned member of the Roche Group, of GDC-0449, a first-in-class hedgehog pathway inhibitor, in patients with advanced basal cell carcinoma (BCC).
The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatitis Day on Life Sciences Connect, a blog exploring the latest news and trends in Life Sciences and updates on the drug pipeline identifying multiple treatments in development that may serve as potential alternatives to Gilead's Sovaldi, currently priced in the United States at $84,000 for 12 weeks of treatment - $1000 per pill.
John Theurer Cancer Center at Hackensack University Medical Center will bring together top neuro-oncologists from around the country for an all day symposium to address new treatment updates and review management of complex cases across a broad array of neuro-oncology specialties.
Higher levels of selenium are associated with a decreased risk of colorectal cancer, according to new research published in the International Journal of Cancer (December).
Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has granted a Priority Review designation to its Supplemental New Drug Application (sNDA) for REVLIMID (lenalidomide) for the treatment of relapsed or refractory multiple myeloma.
› Verified 9 days ago
Karen Mcgoldrick, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 450 Veterans Memorial Pkwy, East Providence, RI 02914 Phone: 401-434-7853 | |
Dr. Marc Alexander Jaffe, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 38 Amaral St, East Providence, RI 02915 Phone: 401-438-3300 Fax: 401-434-5313 | |
Santina Siena, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 450 Veterans Memorial Pkwy, East Providence, RI 02914 Phone: 401-434-7747 Fax: 401-434-7891 | |
Marguerite Vigliani, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 450 Veterans Memorial Pkwy, Suite 101, East Providence, RI 02914 Phone: 401-438-1748 |